RxDoctor Payments Data

Nicole Barossi, APRN

Adult Health · Plymouth, MANPI 1316243322

Payments from drug & device makers

$1,182in general payments, 2019–2025

Across 51 payments — averaging $23.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$236
  • Pfizer$191
  • Novartis$180
  • E.r. Squibb & Sons, L.L.C.$87
  • Alnylam Pharmaceuticals Inc.$76
  • Johnson & Johnson$68
  • plus $344 from 10 others

What the payments were for

  • Food & beverage$1,182100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,182 in reported general payments places this provider in the 80th percentile of 671 adult health providers in Massachusetts.

See all adult health providers in Massachusetts

Medicare billing

Part B allowed, 2024
$55,476
Medicare patients
445
Services billed
869

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban141$159,854
EntrestoSacubitril/Valsartan29$32,295
XareltoRivaroxaban15$19,865
OzempicSemaglutide16$19,227
JardianceEmpagliflozin17$12,253
Repatha SureclickEvolocumab14$12,217
Metoprolol Succinate149$2,348
Atorvastatin Calcium100$1,439
Ezetimibe20$1,050
Rosuvastatin Calcium36$915
Potassium Chloride28$541
Furosemide90$540
Valsartan18$477
Lisinopril41$374
Losartan Potassium36$309

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$191$159,854141 claims
NovartisEntresto$180$32,29529 claims
Johnson & JohnsonXarelto$68$19,86515 claims
Novo NordiskOzempic$61$19,22716 claims
Boehringer IngelheimJardiance$26$12,25317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 671 adult health providers in Massachusetts.

Other adult health in Plymouth

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →